An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
Abstract The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotry...
Guardado en:
Autores principales: | Qi Liao, Ziyu Chen, Yanlin Tao, Beibei Zhang, Xiaojun Wu, Li Yang, Qingzhong Wang, Zhengtao Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3bf5e01a58d45099b95da7f124881fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
por: Vicky Mody, et al.
Publicado: (2021) -
Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Rai C. Silva, et al.
Publicado: (2021) -
Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication
por: Liubing Du, et al.
Publicado: (2021) -
Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
por: Elisa Costanzi, et al.
Publicado: (2021) -
POTENTIAL OF CURATELLA AMARICANA L. AGAINST SARS-COV2: BIOAVAILABILITY, MOLECULAR SIMILARITY AND MOLECULAR DOCKING BETWEEN SECONDARY METABOLITES AND PROTEASE TYPE 3-CHYMOTRYPSIN (3CLPRO)
por: Marcano,Emildo, et al.
Publicado: (2021)